Clarithromycin simvastatin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Discuss a non-interacting antibiotic choice or temporary statin plan
This scenario assesses Clarithromycin simvastatin in a UK pharmacy practice context. Clarithromycin can increase simvastatin exposure and myopathy risk, so an alternative plan should be agreed. The best answer is Discuss a non-interacting antibiotic choice or temporary statin plan because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF